ROYALTY PHARMA PLC- CL A
RPRXNASDAQ🏆 #400 by market capEarnings Nov 3US Equity
$58.22▼ $0.15 (−0.26%)
🌙 After hours$58.22▲ 0.00%Regular close · extended-hours price shownTrack RPRX
Get earnings, price moves & breaking news on Telegram
24h▼ 0.3%
7d▼ 0.5%
14d▼ 0.4%
30d▼ 4.3%
ytd▲ 50.7%
1y▲ 65.3%
🏦Market Cap
$33.52B
Mid Cap
📈Revenue Growth (YoY)
+10.0%
Healthy
📊Gross Margin
—
💵FCF Margin
33.0%
Strong
⚖️P/S Ratio
13.2x
Elevated
Otter Score
68
Fair
ROYALTY PHARMA PLC- CL A
RPRXAnalyst Ratings
Price
$58.22
Total
11
Raised
0
Lowered
0
Avg PT
$62.67
H / L
$66 / $57
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
TD Cowen | Reiterated | Buy | 2026-09-08 | — | — |
JP Morgan | Reiterated | Overweight | 2026-08-07 | — | — |
Citigroup | Reiterated | Buy | 2026-05-07 | — | — |
UBS | Reiterated | Buy | 2026-04-21 | $57.00 | −2.10% |
Morgan Stanley | Reiterated | Overweight | 2026-04-10 | $65.00 | +11.60% |
Goldman Sachs | Reiterated | Buy | 2024-08-14 | $66.00 | +13.40% |
B of A Securities | Reiterated | Buy | 2024-04-12 | — | — |
Tigress Financial | Reiterated | Buy | 2023-04-06 | — | — |
Scotiabank | Reiterated | Outperform | 2022-09-13 | — | — |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-07-13 | — | — |
Cowen & Co. | Reiterated | Outperform | 2020-07-13 | — | — |
Institution
TD Cowen
Reiterated · Buy · 2026-09-08
—
—
JP Morgan
Reiterated · Overweight · 2026-08-07
—
—
Citigroup
Reiterated · Buy · 2026-05-07
—
—
UBS
Reiterated · Buy · 2026-04-21
$57.00
−2.10%
Morgan Stanley
Reiterated · Overweight · 2026-04-10
$65.00
+11.60%
Goldman Sachs
Reiterated · Buy · 2024-08-14
$66.00
+13.40%
B of A Securities
Reiterated · Buy · 2024-04-12
—
—
Tigress Financial
Reiterated · Buy · 2023-04-06
—
—
Scotiabank
Reiterated · Outperform · 2022-09-13
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2020-07-13
—
—
Cowen & Co.
Reiterated · Outperform · 2020-07-13
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space